Open in App
  • Local
  • U.S.
  • Election
  • Politics
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • AI Summarized - US Updates

    ULM's Own Dr. Barabutis Honored as Researcher of the Semester

    2024-05-24
    https://img.particlenews.com/image.php?url=21r9wa_0tLtjn3Q00

    This article contains content summarized with GPT-4 Learn more. It is based on information from ulm.edu, which reflects the perspectives and priorities of the organization. Please consider the specific interests of the source when reading

    Dr. Nektarios Barabutis has been named the Researcher of the Semester for Spring 2024 by the Office of Sponsored Programs and Research (OSPR) at the University of Louisiana Monroe (ULM). Dr. Barabutis, an Associate Professor of Pharmacology in the College of Pharmacy, has contributed significantly to pharmacology since he joined ULM in October 2017.

    His research focuses on the cellular mechanisms behind human diseases, aiming to improve understanding of disease pathogenesis and assist in developing new treatments for severe disorders. He specializes in the molecular network that regulates endothelial barrier function, which is important because vascular leaks can be critical in many serious conditions.

    Dr. Barabutis's work has gained academic recognition, leading to invitations to contribute to prestigious journals and participate in key research panels. He has published 68 peer-reviewed articles in respected journals and was recently invited to submit a review on endothelium regulation to Trends in Cell Biology. He also serves as an editor for several scientific publications, including Data in Brief and MethodsX by Elsevier.

    Since 2018, his research has received consistent external funding, currently supported by the Louisiana Biomedical Research Network. This funding highlights the importance and impact of his work in the biomedical research field.

    Visit here for more details
    Expand All
    Comments / 0
    Add a Comment
    YOU MAY ALSO LIKE
    Most Popular newsMost Popular

    Comments / 0